Aspira Pathlab Diagnostics Ltd vs Earkart Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 0 as of March 2024 .The P/E Ratio of Earkart Limited is 0 as of March 2024 . The Market Cap of Aspira Pathlab & Diagnostics Ltd is ₹ 31.91 crore as of March 2024 .The Market Cap of Earkart Limited is ₹ 0 crore as of March 2024 . The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 5.36 crore as compare to the Mar '25 revenue of ₹ 5.91 crore. This represent the decline of -9.31% The revenue of Earkart Limited for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 0.79 crore as compare to the Mar '25 ebitda of ₹ 1.05 crore. This represent the decline of -24.76% The ebitda of Earkart Limited for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0.42 crore over 5 quarters. This represents a CAGR of 448.81% The net profit of Earkart Limited changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Earkart Limited changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About Earkart Limited

Earkart Limited was originally formed as a Private Limited Company in the name and style of 'Earkart Private Limited' on April 14, 2021 vide Certificate of Incorporation issued by Registrar of Companies, Kanpur.
On October 11, 2021, Rohit Misra acquired a majority of the equity shares from them and became the Promoter of the Company.
Thereafter, the status of the Company was taken public and the name was changed to 'Earkart Limited' dated December 18, 2024 by the Registrar of Companies, Central Processing Centre. Company manufacture and distribute modern hearing aids and related accessories at affordable price across India.
Along with the own manufactured hearing aid, it also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad.
In addition, it offer other products like adjustable foldable walkers and MultiSensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) kits to support mobility and daily needs of physically challenged.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and Earkart Limited

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or Earkart Limited?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of Earkart Limited is 163 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and Earkart Limited?

The stock performance of Aspira Pathlab & Diagnostics Ltd and Earkart Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and Earkart Limited?

As of October 24, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, Earkart Limited stock price is INR ₹119.1.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and Earkart Limited compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and Earkart Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.